MedTrace Logo

Biomarker Study in Tissue Samples From Patients With Acute Myeloid Leukemia

NCT01232842 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2016-07-11

No results posted yet for this study

Summary

RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors identify and learn more about biomarkers related to cancer.

PURPOSE: This research study is studying biomarkers in tissue samples from patients with acute myeloid leukemia.

Conditions

Interventions

GENETIC

cytogenetic analysis

OTHER

HUMARA assay

OTHER

fluorescence activated cell sorting

OTHER

laboratory biomarker analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • Roland Walter, MD, PhD · Fred Hutchinson Cancer Center

Eligibility

Max Age
120 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2016-07-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01232842 on ClinicalTrials.gov